INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
The purpose of this study is to determine whether the combination of two agents, INC280 and bevacizumab, is safe and effective when administered to patients with Glioblastoma Multiforme (GBM) who have progressed after receiving prior therapy or who have unresectable GBM.
创建时间：
2015-09-15
